Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Management and Outcomes of Complications Related to BioZorb Use in Breast-Conserving Surgery: A Retrospective Single-Center Case Series Analysis.
Journal: Ochsner journal
Published: March 19, 2026
Complications after Oncoplastic Breast Reduction and Impact on Time to Adjuvant Therapy.
Journal: Plastic and reconstructive surgery. Global open
Published: February 05, 2024
Can Axillary Ultrasound Identify Node Positive Patients Who can Avoid an Axillary Dissection After Neoadjuvant Chemotherapy?
Journal: The Journal of surgical research
Published: March 02, 2023
OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated Study.
Journal: Hematology/oncology and stem cell therapy
Published: September 25, 2022
Outcomes of Nipple-sparing Mastectomy with Reconstruction after Recent Oncoplastic Wise-pattern Reduction.
Journal: Plastic and reconstructive surgery. Global open
Published: June 01, 2022
Outcomes of Margin Reexcision after Oncoplastic Breast Reduction.
Journal: Plastic and reconstructive surgery. Global open
Published: January 29, 2022
Is Sentinel Lymph Node Biopsy Reliable After Recent Oncoplastic Breast Reduction?
Journal: The American surgeon
Published: May 31, 2021
Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers: An Opportunity to Eliminate Overtreatment and Decrease Testing Costs.
Journal: Hematology/oncology and stem cell therapy
Published: February 03, 2021
The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
Journal: Clinical breast cancer
Published: November 06, 2020
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Journal: Breast cancer research and treatment
Published: September 26, 2020
ASO Author Reflections: Preoperative Nomogram Identifies Patients for Selective Omission of SLNB in Breast Cancer-to Promote Implementation of the Choosing Wisely Campaign Recommendations.
Journal: Annals of surgical oncology
Published: February 18, 2020
Last Updated: 09/26/2026